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CANCER OF OROPHARYNX AND
NASOPHARYNX CLlNICAL
PROGNOESTIC FACTORS ANALYSIS
M. Syguła, B. Pilecki, W. Sąsiadek, M. Goleń,
W. Przeorek, A. Wygoda, K. Składowski
Clinic ot Radiotherapy, Cancer Centre MSC
Institute, Gliwice, Poland
Analysis contains 110 cases ot oropharyngeal
and 112 cases ot nasopharyngeal cancers who
were treated beetwen 1990-1998 in MSC
Centre ot Oncology-Institute, branch Gliwice.
Main part ot histopatological tindings in
oropharyngeal area were squamous cancers,
but undifterentiated type was slightly dominated
than squamous in nasopharyngeal region.
More than halt ot cases in both localisations
were locally advanced [T3,T4] and similar,
nearly 1/3 cases were without nodal
metastases.
Comparisons beetwen mean tumor volumes
indicate on bigger cancer volume, when primary
tumor was located in oropharyngeal area, but
mean nodal volume was much higher in
nasopharyngeal cancer.
Kinetics ot distant metastases were much
higher in nasopharyngeal location ot primary
tumor especially in undifterentiated cases.
Radiotherapy was the main type ot treatment
which was realised in palliative and radical
schedule with conventional and unconventional
tractionation scheme.
Following clinical tactors were underdone
evaluation: T-stage and primary tumor volume,
N-stage with amount and volume ot nodes,
conglomerates ot nodes presence, M-stage,
type ot histological structure and treatment
tactors: tumor and nodal total doses and kind ot
tractionation.
Statistieal methods which were used
contained: single- and multivariate analysis and
logistic regression model.
Conclusion: "Hierarchy ot importance" of the
tactors which were analysed and their influences





AND RADIOTHERAPY IN CERVICAL
CANCER PATlENTS. A REPORT ON
ACUTE TOXICITY
K. Serkies, L. Krasinska, T. Sawieki, J. Jassem
Medical University ot Gdansk
Material and method: Between May 1999 and
January 2001, 41 consecutive cervical caneer
patients (pts) , median age 46 yrs (range 29-68),
were treated with concurrent eisplatin and pelvic
irradiation with curative intent (29 pts FIGO stage
IB "bulky", IIB-IVA) or postoperatively (11 pts who
had positive pelvic Iymph nodes and/or
involvement ot the surgical margin and/or large
and deeply invasive lesion). Adequate bone
marrow function and normai serum creatinine
were required. Cisplatin given as a 60-minute
intusion, was administered weekly at the dose ot
40 mg/sqm (max. 70 mg) tor six eycles.
Antiemetic therapy was routinely given. Three
patients reeeived irradiation on out-patient basis.
Results: A total ot 145 cycles were
administered. The median number ot cisplatin
eycles was 4 (range: 1-6). Overall, 65% ot pts
received at least tour cycles ot cisplatin. The
reasons tor ehemotherapy discontinuation
included low level ot creatinine clearence (2
pts), worsening of performance status (3 pts),
and myoclonia after cisplatin injection (1 pt).
Moderate emesis occurred in one patient, grade
2 leukopenia in two other cases. There were no
severe acute effects precluding the delivery ot
planned radiotherapy. At present six patients are
still on therapy.
Conclusion: Pelvie radiotherapy eombined with
weekly cisplatin is teasible in a routine practice.
This modality is also suitable tor patients treated
on out-patient basis.
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THE RATIONAl FOR OPTIMAL
COMBINATION OF RADlATION
THERAPY AND TAXANES IN ORGAN
PRESERVATlON TREATMENT OF
HEAD AND NECK CANCER
PROJECT OF CLlNICAL STUDY
T. Rutkowski, W. Sąsiadek, A. Mucha,
K. Składowski
Clinie of Radiotherapy, Cancer Centre MSC
Institute, Gliwice. Poland
Rep. Pract. Oncol. Radiother. 6 (1) 2001
Because Docetaxel has both radiosensitizing
properties as well as good anticancer activity by
itselt in squamous celi carcinomas we are going
to attempt concurrent use ot Docetaxel and
radiochemiotherapy in patients with advanced
head and neck cancers (HNC).
Aim: The objective ot this study is to evaluate
the response rate, loco-regional control, disease
- tree survival and overall survival in previously
untreated inoperable HNC patients.
Methods: This is a project ot an open non-
randomized, one centre, phase II, one arm
study. Total planned dose ot RT tor GTV is 68
Gy given in 40 tractions, once daily, 7 times per
week concomitantly with Cis-Platin, Navelbine
and Docetaxel. Eligibility criteria include: proven
HNC not treated betora, good performance
status, normaI bone marrow, liver and renal
tunction, age bellow 60. The regimen is
proposed as tollows: Cis-Platin Lv. 70mg/m2 on
day 1, 22, 43, 64, Navelbine 20mg/m2 Lv. on day
1, 8, 22, 29, 43, 50, 64 and Docetaxel 30
mg/m2lweek or as 1-h intusion ot 60 mg/m2 in
each 7 days ot RT, Ethyol 1000 mg Lv. on day
1, 22, 43 and 250 mg on day 23 - 42.
Radiotherapy 1,7 Gy per traction continuously
on day 23 - 42 and 44 - 63. Different treatment
schedules ot Docetaxel could be used on the
basis ot cellular activity tor a given tumour. So,
biopsy should be obtained tor analysis ot pre-
treatment levels ot apoptosis and oncogenes




MAL RADlATlON THERAPY AND
MONITORING OF TREATMENT
RESULTS IN PATIENTS WITH
ADVANCED NSCLC. ASSESSMENT
OF TOLERANCE AND EARLY
FAILURE
B. Jochymek, M. Dybek, A. Radkowski,
M. Gawlikowicz
Radiotherapy Department ot the Hospital -
Memorial S1. Leszczyński, Katowice.
Aim: The assessment ot the early tailure and
toxicity ot treatment tor the advanced NSCLC
using the accelerated hyperfractional contormal
irradiation _
Material: 13 patients (12 men, 1woman, aged
50 - 74), in good performance status/70-90
points ot Karnotsky scale 1 were treated.
Rep. Pract. Oncol. Radiother. 6 (1) 2001
Patients have been irradiated with 15 MV or 6
MV photon two times a day with 6 hours break
using 1.25 Gy traction to total dose 50 Gy. PTV
ranged trom 599 to 1104 cm3 (mean 858cm3).
Methods: The mean tumor dimension betore
and 6 weeks after tinishing treatment with the
use ot CT have been assessed.
Results: 3 early tailure have been observed,
all outside ot PTV. The 2/3 ot that recurrence
have been recognized by eT. These patients
have been ordered to chemotherapy. The mean
tumor dimension was equal to 2,38 cm 6 weeks
after tinishing ot treatmen1. This means 44%
regression ot the mean tumor dimension. No
side effects and deteriorations ot performance
status have been observed.
Ali patients have tinished the treatment, all are
in tollow up, alive.
Conclusions: The accelerated hyperfractioned
regimen can be carried out in outpatients service
it PTV is smaller than 1000cm3•
Observed early recurrence two months ot
tollow up are connected with a progression ot a
tumor outside ot irradiated volume.
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RETROSPEKTYWNA OCENA
WCZESNYCH I PÓŹNYCH ODCZY-
NÓW POPROMIENNYCH W ŚLUZÓW­
KACH JAMY USTNEJ PO POOPERA-
CYJNYM NAPROMIENIANIU Z PO-
WODU RAKA PRZYUSZNICY
Z. Laskus
Klinika Nowotworów Głowy i Szyi
Centrum Onkologii, Warszawa
Cel pracy: ocena częstości rejestrowanych
odczynów i ich wpływu na jakość życia pacjenta.
Materiał i metoda: W II Zakł. Teleterapii
w latach 1984-1997 leczono 86 chorych z rakiem
przyusznicy. Zebrano retrospektywne dane
z zapisu w historiach chorób, dotyczące
pojawienia się, trwania i nasilenia wczesnych
późnych odczynów popromiennych
w śluzówkach. Oceniono teź przeżycia chorych
(60% przeżyć 5-cioletnich) i porównano je
z danymi z literatury dotyczącymi przeżyć
u pacjentów leczonych samodzielną chirurgią
(20-30% przeżyć 5-cioletnich).
Wyniki: Odczyn wczesny w śluzówkach
opisano u 50 chorych (58%), odczyn późny
u 17 chorych (19,8%). Wyraźną kserostomię
(przejaw odczynu późnego II stopnia) klinicznie
stwierdzono u 2 chorych, w tym po 2 latach
od rozpoczęcia leczenia - u 1 chorego. Częstą
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